Response to Shao Et Al.-Reference-Cited by-同舟云学术

Response to Shao Et Al.

Published:2020-12-13 Issue:3 Volume:36 Page:619-620
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Seeto Alexander H¹^ORCID,Abrahamsen Bo²³⁴^ORCID,Ebeling Peter R⁵⁶^ORCID,Rodríguez Alexander J²⁵^ORCID

Affiliation:

1. School of Medicine Griffith University Gold Coast Australia

2. OPEN‐Odense Patient Data Explorative Network, Institute of Clinical Research University of Southern Denmark Odense Denmark

3. Musculoskeletal Pharmaco‐ and Device Epidemiology, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences University of Oxford Oxford UK

4. Department of Medicine Holbæk Hospital Holbæk Denmark

5. Bone and Muscle Health Research Group, Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences Monash University, Monash Medical Centre Clayton Australia

6. Australian Institute for Musculoskeletal Science St. Albans Australia

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4224

Reference4 articles.

1. Cardiovascular safety of denosumab across multiple indications: a systematic review and meta‐analysis of randomized trials;Seeto AH;J Bone Miner Res.,2020

2. Cardiovascular Safety of Denosumab Across Multiple Indications

3. Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density

4. Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women